Legal Representation
Attorney
Sara M. Bauer
USPTO Deadlines
Next Deadline
60 days remaining
Non-Final Action Mailed
Due Date
September 13, 2025
Extension Available
Until December 13, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 13, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 13, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 13, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 12, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 2, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 2, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 31, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals and biological preparations for use in the biological, biotechnological, medical and pharmaceutical industries; medicinal and biological preparations for research, laboratory, and medical laboratory use, namely, preparations used in the manufacture of pharmaceuticals for treating neurological disorders with brain-penetrant small molecules as well as inflammatory diseases and metabolic disorders
Class 005
Pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, neurological disorders with brain-penetrant small molecules as well as inflammatory diseases and metabolic disorders.
Class 042
Research and development in the fields of therapeutics, pharmaceutical and biotechnology; pharmaceutical research and development services; research and development of therapeutics and pharmaceuticals; consulting services in the field of pharmaceuticals, namely, pharmaceutical and therapeutic research; pharmaceutical research for small molecule drug discovery and development; medical research; providing medical and scientific research information in the fields of therapeutics, biologicals and pharmaceuticals
Additional Information
Design Mark
The mark consists of undulating and intersecting stylized waves connected by multiple endpoints above the stacked words "NEUROLAMBDA" and "THERAPEUTICS".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042